Virus Outbreak: FDA grants conditional nod to remdesivir drug

PREPAREDNESS: A CECC adviser said that information about the drug has been positive, so most specialists support its import, which will help if the virus surges

Taipei Times
Date: May 31, 2020
By: Lee I-chia / Staff reporter

Minister of Health and Welfare Chen Shih-chung, third left, and other officials in Tainan yesterday hold movie poster-styled prints by painter Yen Chen-fa, third right, with the text “The great disease prevention war.”
Photo: CNA

The Food and Drug Administration (FDA) has conditionally approved the antiviral drug remdesivir to treat people with severe COVID-19, the Central Epidemic Command Center (CECC) said yesterday.

At the CECC’s daily news conference in Taipei, Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center, said that no new cases have been confirmed, while 421 people have been released from isolation after contracting the novel coronavirus.

“Taiwan remains the same — with no new domestic cases reported in 48 consecutive days,” Chen said. “However, the COVID-19 situation globally is still serious and almost 6 million cases have been confirmed, so we have to be extra careful about border controls.”

After a specialist meeting on Friday, the FDA approved remdesivir to treat people with severe COVID-19, Chen said.    [FULL  STORY]

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy

This site uses Akismet to reduce spam. Learn how your comment data is processed.